Prenatal Screening: Current Practice, New Developments, Ethical Challenges
Prenatal screening pathways, as nowadays offered in most Western countries consist of similar tests. First, a risk-assessment test for major aneuploides is offered to pregnant women. In case of an increased risk, invasive diagnostic tests, entailing a miscarriage risk, are offered. For decades, only...
Authors: | ; ; |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Wiley-Blackwell
[2015]
|
In: |
Bioethics
Year: 2015, Volume: 29, Issue: 1, Pages: 1-8 |
IxTheo Classification: | NCH Medical ethics |
Further subjects: | B
Informed Consent
B reproductive autonomy B ethical issues B prenatal screening B Noninvasive prenatal testing |
Online Access: |
Volltext (Verlag) Volltext (doi) |
MARC
LEADER | 00000caa a22000002 4500 | ||
---|---|---|---|
001 | 1727702085 | ||
003 | DE-627 | ||
005 | 20210811161411.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200824s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/bioe.12123 |2 doi | |
035 | |a (DE-627)1727702085 | ||
035 | |a (DE-599)KXP1727702085 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
084 | |a 1 |2 ssgn | ||
100 | 1 | |a Jong, Antina de |e VerfasserIn |4 aut | |
245 | 1 | 0 | |a Prenatal Screening |b Current Practice, New Developments, Ethical Challenges |
264 | 1 | |c [2015] | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Prenatal screening pathways, as nowadays offered in most Western countries consist of similar tests. First, a risk-assessment test for major aneuploides is offered to pregnant women. In case of an increased risk, invasive diagnostic tests, entailing a miscarriage risk, are offered. For decades, only conventional karyotyping was used for final diagnosis. Moreover, several foetal ultrasound scans are offered to detect major congenital anomalies, but the same scans also provide relevant information for optimal support of the pregnancy and the delivery. Recent developments in prenatal screening include the application of microarrays that allow for identifying a much broader range of abnomalities than karyotyping, and non-invasive prenatal testing (NIPT) that enables reducing the number of invasive tests for aneuploidies considerably. In the future, broad NIPT may become possible and affordable. This article will briefly address the ethical issues raised by these technological developments. First, a safe NIPT may lead to routinisation and as such challenge the central issue of informed consent and the aim of prenatal screening: to offer opportunity for autonomous reproductive choice. Widening the scope of prenatal screening also raises the question to what extent ‘reproductive autonomy’ is meant to expand. Finally, if the same test is used for two different aims, namely detection of foetal anomalies and pregnancy-related problems, non-directive counselling can no longer be taken as a standard. Our broad outline of the ethical issues is meant as an introduction into the more detailed ethical discussions about prenatal screening in the other articles of this special issue. | ||
601 | |a Challenger | ||
650 | 4 | |a NIPT | |
650 | 4 | |a ethical issues | |
650 | 4 | |a Informed Consent | |
650 | 4 | |a prenatal screening | |
650 | 4 | |a reproductive autonomy | |
652 | |a NCH | ||
700 | 1 | |a Lith, Jan M. M. van |e VerfasserIn |4 aut | |
700 | 1 | |a Maya, Idit |e VerfasserIn |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 29(2015), 1, Seite 1-8 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2015 |g number:1 |g pages:1-8 |
856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12123 |x Verlag |
856 | |u https://doi.org/10.1111/bioe.12123 |x doi |3 Volltext | ||
951 | |a AR | ||
ELC | |a 1 | ||
ITA | |a 1 |t 1 | ||
LOK | |0 000 xxxxxcx a22 zn 4500 | ||
LOK | |0 001 374240265X | ||
LOK | |0 003 DE-627 | ||
LOK | |0 004 1727702085 | ||
LOK | |0 005 20210811161411 | ||
LOK | |0 008 200824||||||||||||||||ger||||||| | ||
LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
LOK | |0 092 |o n | ||
LOK | |0 852 |a DE-Tue135 | ||
LOK | |0 852 1 |9 00 | ||
LOK | |0 935 |a ixzs |a ixzo | ||
LOK | |0 936ln |0 1550736558 |a NCH | ||
ORI | |a SA-MARC-ixtheoa001.raw | ||
STA | 0 | 0 | |a Noninvasive prenatal testing |
STF | 0 | 0 | |a 非侵入性胎兒染色體基因檢測 |
STH | 0 | 0 | |a Неинвазивное пренатальное тестирование |
STI | 0 | 0 | |a Μη επεμβατικός προγεννητικός έλεγχος |
SYE | 0 | 0 | |a Nicht invasiver pränataler Test,Nicht-invasiver Pränataltest,Mütterlicher Bluttest,Non-invasive prenatal testing |